MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.58

+1.4%

Nov 5 12:44 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	10/3/2007 4:34:56 AM
	of 2240

Wednesday October 3, 08:01 AM Genmab gets milestone payment as partner Roche applies for trials with antibody COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Genmab AS said it will receive a milestone payment from its partner Roche as the Swiss group has filed a clinical trial application with British regulators for an antibody developed by Genmab . The size was not disclosed. Genmab's financial guidance for 2007 remains unchanged, the group added. Under its agreement with Roche, Genmab develops antibodies for treatment of a range of disease targets identified by the Swiss group, and receives milestone payments and royalties based on successful products. The announced milestone payment is Genmab's eleventh under the partnership with Roche...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next